DECISION OF THE EEA JOINT COMMITTEE No 177/2022

of 10 June 2022

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/1877]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

(1) Regulation (EU) 2022/112 of the European Parliament and of the Council of 25 January 2022 amending Regulation (EU) 2017/746 as regards transitional provisions for certain in vitro diagnostic medical devices and the deferred application of conditions for in-house devices  ( 1 ) is to be incorporated into the EEA Agreement.

(2) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following is added in point 12 (Regulation (EU) 2017/746 of the European Parliament and of the Council) of Chapter XXX of Annex II to the EEA Agreement:

‘, as amended by:

— 32022 R 0112 : Regulation (EU) 2022/112 of the European Parliament and of the Council of 25 January 2022 ( OJ L 19, 28.1.2022, p. 3 ).’

Article 2

The text of Regulation (EU) 2022/112 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 11 June 2022, provided that all the notifications under Article 103(1) of the EEA Agreement have been made  ( * ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 10 June 2022.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

( 1 )    OJ L 19, 28.1.2022, p. 3 .

( * )   No constitutional requirements indicated.